Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2024-12-17 00:00:00 ET · period of report 2024-12-16 · accession 0001415889-24-029683 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-17 | 2024-12-16 | OLMA | Zojwalla Naseem | Chief MEDICAL Off | M - OptEx | $4.87 | +14.0K | 129.5K | +12% | +$68.2K |
| D | 2024-12-17 | 2024-12-16 | OLMA | Zojwalla Naseem | Chief MEDICAL Off | M - OptEx | $0.00 | -14.0K | 112.8K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-16 | M | A | 14,000 | $4.87 | 129,509 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-16 | M | D | 14,000 | $0.00 | 112,840 | D | $4.87 · — to 2033-01-31 | 14,000 Common Stock | (F1) 25% of the shares subject to the option vested on February 1, 2024 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. |